Phosgene Poisoning Caused by the Use of Chemical Paint Removers Containing Methylene Chloride in Ill-Ventilated Rooms Heated by Kerosene Stoves

por Gerritsen, W. B., Buschmann, C. H.
Publicado 1960

Metastatic castration-resistant prostate cancer: new therapies, novel combination strategies and implications for immunotherapy

por Drake, CG, Sharma, P, Gerritsen, W
Publicado en Oncogene (2013)

Overexpression of Bcl2 abrogates chemo- and radiotherapy-induced sensitisation of NCI-H460 non-small-cell lung cancer cells to adenovirus-mediated expression of full-length TRAIL

por Abou El Hassan, M A I, Mastenbroek, D C J, Gerritsen, W R, Giaccone, G, Kruyt, F A E
Publicado 2004

S48. Biomarker development for ipilimumab and prostate GVAX treatment

por de Gruijl, T, Santegoets, S, Stam, A, Lougheed, S, Jooss, K, Sacks, N, Harding, T, Hege, K, Gerritsen, W, van den Eertwegh, A
Publicado 2014

Redirecting Coronavirus to a Nonnative Receptor through a Virus-Encoded Targeting Adapter

por Verheije, M. H., Würdinger, T., van Beusechem, V. W., de Haan, C. A. M., Gerritsen, W. R., Rottier, P. J. M.
Publicado 2006

Cloning and characterization of human liver cytosolic beta-glycosidase.

por de Graaf, M, van Veen, I C, van der Meulen-Muileman, I H, Gerritsen, W R, Pinedo, H M, Haisma, H J
Publicado 2001

Potentiation of radiation therapy by the oncolytic adenovirus dl1520 (ONYX-015) in human malignant glioma xenografts

por Geoerger, B, Grill, J, Opolon, P, Morizet, J, Aubert, G, Lecluse, Y, van Beusechem, V W, Gerritsen, W R, Kirn, D H, Vassal, G
Publicado 2003

A fully human anti-Ep-CAM scFv-beta-glucuronidase fusion protein for selective chemotherapy with a glucuronide prodrug

por de Graaf, M, Boven, E, Oosterhoff, D, van der Meulen-Muileman, I H, Huls, G A, Gerritsen, W R, Haisma, H J, Pinedo, H M
Publicado 2002

Targeting non-human coronaviruses to human cancer cells using a bispecific single-chain antibody

por Würdinger, T, Verheije, M H, Raaben, M, Bosch, B J, de Haan, C A M, van Beusechem, V W, Rottier, P J M, Gerritsen, W R
Publicado en Gene Ther (2005)

Advances in targeted alpha therapy for prostate cancer

por De Vincentis, G, Gerritsen, W, Gschwend, J E, Hacker, M, Lewington, V, O’Sullivan, J M, Oya, M, Pacilio, M, Parker, C, Shore, N, Sartor, O
Publicado en Ann Oncol (2019)

S100 protein content of umbilical cord blood in healthy newborns in relation to mode of delivery

por Wirds, J, Duyn, A, Geraerts, S, Preijer, E, van Diemen-Steenv..., J A A M, van Leeuwen, J H S., Haas, F, Gerritsen, W, de Boer, A, Leusink, J
Publicado 2003

Secreted and tumour targeted human carboxylesterase for activation of irinotecan

por Oosterhoff, D, Pinedo, H M, van der Meulen, I H, de Graaf, M, Sone, T, Kruyt, F A, van Beusechem, V W, Haisma, H J, Gerritsen, W R
Publicado 2002

Soluble Receptor-Mediated Targeting of Mouse Hepatitis Coronavirus to the Human Epidermal Growth Factor Receptor

por Würdinger, T., Verheije, M. H., Broen, K., Bosch, B. J., Haijema, B. J., de Haan, C. A. M., van Beusechem, V. W., Gerritsen, W. R., Rottier, P. J. M.
Publicado 2005

Adenoviral vector-mediated expression of a gene encoding secreted, EpCAM-targeted carboxylesterase-2 sensitises colon cancer spheroids to CPT-11

por Oosterhoff, D, Overmeer, R M, de Graaf, M, van der Meulen, I H, Giaccone, G, van Beusechem, V W, Haisma, H J, Pinedo, H M, Gerritsen, W R
Publicado 2005

Antibody-mediated targeting of viral vectors to the Fc receptor expressed on acute myeloid leukemia cells

por Würdinger, T, Verheije, M H, van der Aa, L M, Bosch, B J, de Haan, C A M, van Beusechem, V W, Gerritsen, W R, Rottier, P J M
Publicado en Leukemia (2006)

HGF/SF and its receptor c-MET play a minor role in the dissemination of human B-lymphoma cells in SCID mice

por Weimar, I S, Weijer, K, Berk, P C M van den, Muller, E J, Miranda, N, Bakker, A Q, Heemskerk, M H M, Hekman, A, Gast, G C de, Gerritsen, W R
Publicado 1999

Different susceptibility of osteosarcoma cell lines and primary cells to treatment with oncolytic adenovirus and doxorubicin or cisplatin

por Graat, H C A, Witlox, M A, Schagen, F H E, Kaspers, G J L, Helder, M N, Bras, J, Schaap, G R, Gerritsen, W R, Wuisman, P I J M, van Beusechem, V W
Publicado 2006

Inhibition of platelet function by abciximab or high-dose tirofiban in patients with STEMI undergoing primary PCI: a randomised trial

por van Werkum, J.W., Gerritsen, W.B.M., Kelder, J.C., Hackeng, C.M., Ernst, S.M., Deneer, V.H.M., Suttorp, M.J., Rensing, B.J.W.M., Plokker, H.W.M., ten Berg, J.M.
Publicado 2007

Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of >2 years of follow-up

por Fradet, Y, Bellmunt, J, Vaughn, D J, Lee, J L, Fong, L, Vogelzang, N J, Climent, M A, Petrylak, D P, Choueiri, T K, Necchi, A, Gerritsen, W, Gurney, H, Quinn, D I, Culine, S, Sternberg, C N, Nam, K, Frenkl, T L, Perini, R F, de Wit, R, Bajorin, D F
Publicado en Ann Oncol (2019)

Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma

por Bellmunt, J., de Wit, R., Vaughn, D.J., Fradet, Y., Lee, J.-L., Fong, L., Vogelzang, N.J., Climent, M.A., Petrylak, D.P., Choueiri, T.K., Necchi, A., Gerritsen, W., Gurney, H., Quinn, D.I., Culine, S., Sternberg, C.N., Mai, Y., Poehlein, C.H., Perini, R.F., Bajorin, D.F.
Publicado en N Engl J Med (2017)